InBio has extended its recombinant protein development efforts to include viral proteins relevant to allergy and asthma: Human Rhinovirus-16 (HRV-16) surface proteins VP1, VP2, and VP0 (a fusion of VP2 and VP4).
![Rhinovirus-Protein](https://inbio.com/wp-content/uploads/2023/02/Rhinovirus-Protein.png)
Key tools for immune mechanism research.
HRV capsid proteins are useful in the study of the immune mechanisms involved in rhinovirus-induced asthma exacerbations, as well as for epitope mapping, T-cell responses and diagnostic purposes.
Normally, rhinovirus proteins are difficult to express individually, due to extensive protein-protein interactions. Using proprietary purification and manufacturing schemes, InBio has developed purified individual proteins HRV-16 VP1, VP2, and VP0. Immune reactivity is validated by IgG antibody ELISA using serum samples from Rhinovirus patients. All of it under an ISO 9001:2015 certified Quality Management System.